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Complications of Brucella Infection among Adults:
An 18-Year Retrospective Evaluation
Aim: Brucellosis is a systemic infection in which any organ or system of the body can be involved. We evaluate
here complications and involvement of Brucella infection in Erzurum, Turkey.
Materials and Methods: We analyzed retrospectively 216 adult (89 female and 127 male) cases of
brucellosis who were diagnosed and treated in the Infectious Disease Clinic of Atatürk University Research
Hospital from 1985 to 2002. The diagnosis was based on clinical findings and serologic results and/or blood
culture confirmations.
Results: All isolates from cultures were identified as Brucella melitensis biotype 1. Skeletal complications were
the most frequent, found in 147 (68.1%) cases, followed by nervous system 9 (4.2%), cutaneous 9 (4.2%),
genitourinary system 7 (5.5%), cardiovascular system 7 (3.2%), gastrointestinal system 7 (3.2%), and
hematological system 6 (2.8%) complications.
Conclusions: Primary health care physicians should keep in mind the clinical and laboratory findings of
Brucella complications.
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Eriﬂkinlerde Brusella ‹nfeksiyonlar›n›n Komplikasyonlar›:
18 Y›ll›k Retrospektif De¤erlendirme
Amaç: Brusellozis vücuttaki tüm organ ve sistemleri tutabilen sistemik bir infeksiyondur. Çal›ﬂmam›zda;
Erzurum ve çevresindeki Brusellozlu olgularda görülen komplikasyonlar›n de¤erlendirilmesi amaçland›.
Yöntem ve Gereç: 1985-2002 y›llar› aras›nda Atatürk Üniversitesi T›p fakültesi Araﬂt›rma Hastanesi
‹nfeksiyon Hastal›klar› Klini¤ine müracaat eden ve bruselloz tan›s› konularak tedavi edilen 89 kad›n ve 127
erkek olmak üzere toplam 216 hastada görülen komplikasyonlar retrospektif olarak de¤erlendirildi. Hastalar›n
tan›s›; klinik bulgular, serolojik test ve/veya kan kültürü sonuçlar›na göre konuldu.
Bulgular: Tüm izolatlar Brucella melitensis biyotip 1 olarak saptand›. En s›k komplikasyon görülme oran› kas
iskelet sistemine aitti (147 olguda %68.1), bu oran› %5.5 (7 olgu) ile ürogenital sistem, %4.2 (9 olgu) ile
santral sinir sistemi, %3.2 (7 olgu) ile kardiovasküler sistem ve gastrointestinal sistem, %2.8 (6 olgu) ile
hematolojik sistem izliyordu.
Sonuç: Tüm pratisyen ve uzman hekimlerin brusellozun komplikasyonlar›n›n klinik ve laboratuar bulgular›
konusunda dikkatli olmalar› ve bu hastal›¤› hat›rlamalar› gereklidir.
Anahtar Sözcükler: Brucellozis, komplikasyon, Brucella türleri, tan›

Received: August 23, 2005
Accepted: December 07, 2006

Correspondence

Mustafa ERTEK
Refik Saydam National Hygiene
Center, S›hhiye, Ankara TURKEY
ertekmustafa@hotmail.com

Introduction
Brucellosis is a zoonosis widely distributed around the world. In humans, brucellosis
behaves as a systemic infection with a very heterogeneous clinical spectrum. The
heaviest disease burden lies in countries of the Mediterranean basin and Arabian
Peninsula, and the disease also occurs heavily in India, Mexico, and South and Central
America. Disease incidence and prevalence rates vary widely among nations. Due to
variable reporting, true estimates in endemic areas are unknown. Incidence rates of 1.270 cases per 100,000 people are reported (1). The incidence of this disease in Turkey
is 23 per 100,000 per annum (source: Republic of Turkey, Ministry of Health, Brucella
statistical data for 1970-2004) (2).

Brucella species are named for their primary host species and are further subdivided into
biovars based on serologic agglutination with smooth lipopolysaccharide (S-LPS) associated
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antigens M and A. Brucella melitensis is found primarily in
goats and sheep, but may also be found in cattle because
of indirect contact with infected sheep and goat flocks
that have contaminated pastures from which fodder was
harvested for lactating cows. B. melitensis is divided into
three biovars (1-3). Brucella abortus is pathogenic for
cattle, but can also infect sheep, goats, canines, horses
and humans. The species is comprised of severe biovars
(1-6 and 9). Biovars 7 and 8 are no longer valid. Brucella
suis contains five biovars: biovars 1, 2 and 3 are found in
swine, biovar 4 is found in reindeer and caribou in the
arctic regions of North America and Russia, and biovar 5
causes infections in rodents. Brucella canis strains
comprise a single biovar and occur in dogs. B. abortus, B.
melitensis, B. suis and B. canis can cause infection in
humans. Other species, Brucella ovis and Brucella
neotomae, have not been shown to cause human
infection. B. melitensis is considered the most virulent
species, followed by B. suis and B. abortus. B. canis rarely
causes infections in humans, and most infection has been
acquired in the laboratory. The protean complications
associated with Brucella infections are not generally seen
in human B. canis infections (3,4).
The clinical features of brucellosis are not diseasespecific; almost every organ can be affected. The
prevalence and pattern of complications depend on the
strain of Brucella infecting the individual and the duration
of the disease (5). In this study, all patients with
brucellosis were investigated in more detail with respect
to complications, including skeletal, cardiovascular,
pulmonary, abdominal, genitourinary, central nervous
system (CNS), hematological and cutaneous.
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identified to the species level by using the following test:
agglutination with the specific B. abortus and B.
melitensis antisera, H2S production, urea hydrolysis, and
growth on media with basic fuchsin and thionine. All
strains tested were identified as B. melitensis biotype 1.
Sacroiliitis, spondylitis, peripheral arthritis, and orchitis
were defined by appropriate findings on physical
examination and relevant radiographic, radionuclide, and
tomographic studies. All patients with suspected Brucella
endocarditis
were
studied
by
transthoracic
echocardiography, with the definitive clinical diagnosis
made in accordance with Duke’s criteria (6). Hepatic
complications were defined as the presence of a five-fold
or greater rise in normal levels of aspartate
aminotransferase (AST) or alanine aminotransferase
(ALT), or jaundice. In addition, completed history and
physical examination of all patients were reviewed; tests
for complete blood count, erythrocyte sedimentation
rate, rheumatoid factor (RF), C-reactive protein (CRP),
blood chemistry profile and urine analysis were
performed in all patients. In suspected cases, lumbar
puncture and bone morrow biopsy were performed for
differential diagnosis of pancytopenia.

Results
In our study, 216 (127 male and 89 female) patients
with brucellosis were analyzed. Signs and symptoms of
brucellosis in this series reflected a combination of
systemic illness with certain manifestations. Table 1 lists
the main symptoms and signs noted on presentation.
Arthralgia, malaise, sweating and fever were the main
Table 1. Clinical characteristics in 216 patients with brucellosis.

Materials and Methods
The present study was retrospectively carried out at
Atatürk University Medical Faculty Hospital, Department
of Clinical Bacteriology and Infectious Diseases, between
January 1985 and December 2002. Our hospital serves a
population of 2.5 million inhabitants, and is the largest
(1200-bed) hospital in the city of Erzurum in the Eastern
Anatolian region of Turkey. The diagnostic criteria were
a standard tube agglutination titer of 1/160 or more for
anti-Brucella antibodies in the presence of compatible
clinical findings (fever, night sweats, arthralgia,
hepatomegaly, splenomegaly, and lymphadenopathy) and
isolation of a Brucella spp. from blood or bone marrow
cultures. The bacteria isolated from the cultures were
378

Symptoms

N%

Sign

N%

Arthralgia

181 (84)

Splenomegaly

76 (35)

Malaise

173 (80)

Hepatomegaly

58 (27)

Sweating

168 (78)

Lymphadenopathy

11 (5)

Anorexia

157 (73)

Heart murmur

4 (2)

Fever

156 (72)

Nuchal rigidity

5 (2)

Chills

148 (68)

Testicular swelling

7 (6)

Back pain

117 (54)

Rash

9 (4)

Headache

115 (53)

Jaundice

2 (1)

Myalgia

94 (43)

Scrotal pain

7 (6)
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presenting symptoms overall. The commonest
abnormalities on physical examination were fever (72%),
hepatomegaly (27%) and splenomegaly (35%).
Osteoarticular involvement was found in 147 patients
(68.1%). Seven (6%) patients had orchiepididymitis
involvement. Cutaneous, nervous, hepatitis, endocarditis,
thrombophlebitis and hematological involvement were
found in 9 (4.2%), 9 (4.2%), 7 (3.2%), 5 (2.3%), 2
(0.9%) and 6 (2.8%) patients, respectively. The
commonest
hematological
abnormalities
were
thrombocytopenia (1.9%) and pancytopenia (0.9%).

species known to cause disease in humans, B. melitensis
is the most virulent and causes the most severe and acute
cases of brucellosis with disabling complications (1).
Musculoskeletal involvement is seen as the most frequent
complication of brucellosis; however, its prevalence may
vary from 0% to 70% (7). The diversity of criteria used
for the diagnosis of musculoskeletal involvement in
brucellosis may cause variations in the results obtained by
different researchers. Osteoarticular manifestations
include peripheral arthritis, sacroiliitis, spondylitis,
osteomyelitis, and bursitis (8,9).

According to the microbiological examinations, all
isolates obtained from cultures were identified as B.
melitensis biotype 1.

In our study, the ratio of patients with
musculoskeletal complications of brucellosis (68.1%) was
very high. The most common skeletal complication was
sacroiliitis, not osteomyelitis and bursitis. In countries
where infection with B. melitensis predominates, the
sacroiliac joint is the most frequently involved
musculoskeletal site. Infection of the joints is the most
frequent localized complication of brucellosis and a
common cause of infectious arthritis in countries where
the disease is endemic (7).

The
most
common
complications
were
musculoskeletal and nervous system involvement and
orchitis. In the skeletal system, sacroiliitis (56.2%) was
the most common complication, followed by spondylitis
(27.9%) and peripheral polyarthritis (21.3%). The other
complications are shown in Table 2.

Discussion
Brucellosis complications are a major medical problem
in countries where brucellosis is still endemic, as in our
region of eastern Anatolia, Turkey. Among the four

Table 2. Complications in 216 patients with brucellosis.
Complications
Skeletal system

N

%

147

(68.1)

Spondylitis

63

(27.9)

Sacroiliitis

118

(56.2)

Peripheral monoarthritis

19

(8.8)

Peripheral polyarthritis

46

(21.3)

Nervous system

9

(4.2)

Cutaneous

9

(4.2)

Orchitis

7

(5.5)

Endocarditis

5

(2.3)

Thrombophlebitis

2

(0.9)

Hematologic

6

(2.8)

4

(1.9)

2

(0.9)

7

(3.2)

Thrombocytopenia
Pancytopenia
Gastrointestinal system
Hepatitis

Meningitis,
encephalitis,
meningoencephalitis,
cerebellar ataxia, myelitis, radiculitis, peripheral neuritis,
Guillain-Barré syndrome, and cranial nerve palsy have
occurred in patients with brucellosis and involvement of
the nervous system (10,11). Neurological involvement of
the CNS has been detected in 2% to 5% of the patients
with brucellosis, in both the presence and absence of
systemic illness (12). Meningitis is the most frequent CNS
complication (13). In the present study, meningitis was
seen as a CNS complication (4.2%).
Cutaneous lesions occur in about 5% of patients with
brucellosis. In the present study, cutaneous complications
were the third most frequent (4.2%). The lesions were
maculopapular and erythema nodosum. Cutaneous
findings in our cases were similar to other reported
studies (14-16). It is important to emphasize that
cutaneous lesions are not specific to brucellosis and may
be seen in a variety of other dermatologic diseases caused
by many agents.
Cardiovascular localization of Brucella infection can
result in endocarditis, myocarditis or pericarditis. The
aortic valve has been commonly involved, followed by the
mitral valve alone or both valves concurrently. The aortic
valve is affected in 75% of patients, and 50% of affected
valves were previously healthy. Despite its low frequency,
endocarditis is a very severe complication of brucellosis,
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since its appearance is associated with a high mortality
rate. Endocarditis was present in 80% of brucellosis
patients who died, which highlights the importance of its
suspicion in order to establish timely diagnosis.
Endocarditis occurs in less than 2% of patients
worldwide; however, in endemic areas, it may complicate
7%-10% of patients (17). In a previous study of 530
patients with brucellosis, only 6 (1.5%) had endocarditis
(18). In the present study endocarditis was present in 7
patients (4.2%).
Epididymoorchitis is the most common genitourinary
complication. Brucellosis is a relatively common cause of
Brucella epididymoorchitis in geographic areas where B.
melitensis is endemic. The incidence of epididymoorchitis
in brucellosis is estimated at 2%-20% (19). Yurdakul et
al. (20) reported a rate of 17% in their series and a study
from India reported orchitis in 6 (6%) of 160 patients
with brucellosis over a 12-year period (21). Khan (22)
investigated 100 patients with brucellosis in Saudi Arabia
and found testicular involvement in 6%. In the present
study, epididymoorchitis occurred in 5.5% of all patients
with brucellosis.
Liver involvement is frequently seen in brucellosis,
although this involvement usually has little clinical
importance and is usually limited to soft painless
hepatomegaly, or slight increases in levels of
aminotransferases. Liver abscess is uncommon in
brucellosis. Brucella is also a rare cause of acute
cholecystitis, pancreatitis and spontaneous bacterial
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peritonitis (4). In this study, no cases of liver abscess,
cholecystitis, pancreatitis or peritonitis were present, but
7 hepatitis (3.2%) cases were seen. Clinical features of
these cases were those of viral hepatitis.
Mild hematological abnormalities, such as anemia and
leukopenia, are common in the course of human
brucellosis (23). Thrombocytopenia is less common,
having been reported in only 1-8% of cases, and it is
rarely severe enough to cause bleeding (24). Akdeniz et
al. (25) reported that anemia was present in 128 patients
(55%), leukopenia in 49 (21%), thrombocytopenia in 59
(26%) and pancytopenia in 18 (8%) patients. In another
study, anemia was found in 74% of patients, leukopenia
in 45%, neutropenia in 21%, lymphopenia in 63%,
thrombocytopenia in 39.5%, and pancytopenia in 21%
(26). In our study, thrombocytopenia was found in 4
patients (1.9%) and pancytopenia in 2 patients (0.9%).
The focal complications can affect any organ or
system, which explains why these patients are not always
seen by infectious disease specialists; therefore, many
other medical and surgical specialists may diagnose the
brucellosis. Even when there is a high degree of suspicion,
the diagnosis of brucellosis is not always easy. Diagnosis
of focal forms of brucellosis can occasionally be difficult,
not only because the physician may not consider it as the
cause of the clinical picture but also because even when it
is considered, the yields of blood and non-blood sample
cultures of patients with these forms are low.
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